| Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] |
The following table summarizes the components of the loss per common share calculation (in thousands, except per share amounts): | | | Three Months ended
March 31, | | Nine Months ended
March 31, | | | | | 2017 | | 2016 | | 2017 | | 2016 | | | Basic and diluted numerator: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Net loss attributable to iBio, Inc. | | $ | (3,913) | | $ | (3,036) | | $ | (10,203) | | $ | (7,087) | | | Preferred stock dividends | | | 26 | | | - | | | 26 | | | - | | | Net loss available to iBio, Inc. stockholders | | $ | (3,939) | | $ | (3,036) | | $ | (10,229) | | $ | (7,087) | | | | | | | | | | | | | | | | | | Basic and diluted denominator: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Weighted-average common shares outstanding | | | 89,109 | | | 81,158 | | | 89,109 | | | 78,587 | | | | | | | | | | | | | | | | | | Per share amount | | $ | (0.04) | | $ | (0.04) | | $ | (0.11) | | $ | (0.09) |
|
|
The following table summarizes the components of the earnings (loss) per common share calculation (in thousands, except per share amounts): | | | Years ended
June 30, | | | | | 2016 | | 2015 | | | Basic and diluted numerator: | | | | | | | | | | | | | | | | | | Net loss available to iBio, Inc. stockholders | | $ | (9,764) | | $ | (6,625) | | | | | | | | | | | | Basic and diluted denominator: | | | | | | | | | | | | | | | | | | Weighted-average common shares outstanding | | | 80,973 | | | 71,495 | | | | | | | | | | | | Per share amount | | $ | (0.12) | | $ | (0.09) | |
|